Literature DB >> 1737591

The prognostic value of argyrophil nucleolar organiser regions (AgNORs) in colorectal cancer.

Z Rayter1, P Surtees, G Tildsley, C Corbishley.   

Abstract

Argyrophil nucleolar organiser regions (AgNORs) are increased in a variety of malignant cells compared with normal cells, and a recent study has claimed that AgNORs have prognostic value in colorectal cancer. We have studied the AgNOR counts in tumours from 95 colonic resections performed in 94 patients in whom a minimum 5 year follow-up was available. In 71 pathological specimens adjacent normal mucosa was also examined. There was a significant difference between AgNORs per cell in normal mucosa (median 1.46, range 1.10-1.80) compared with tumour cells (median 1.92, range 1.42-2.95, P less than 0.001). There were no significant differences in average AgNORs per cell between tumours in each Dukes' stage or category of differentiation. The average AgNORs per cell in tumours of patients surviving disease-free for 5 years was the same as that in tumours of patients dying of colonic cancer recurrence. We conclude that AgNORs have no prognostic value in colorectal cancer and are not correlated with Dukes' staging or differentiation of the tumour.

Entities:  

Mesh:

Year:  1992        PMID: 1737591

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  3 in total

1.  The prognostic value of nucleolar organiser regions in colorectal cancer: a 5-year follow-up study.

Authors:  Z Rayter; C Corbishley
Journal:  Ann R Coll Surg Engl       Date:  1992-09       Impact factor: 1.891

2.  Relationship between morphological diversity and AgNORs or cathepsin B expression in colorectal cancers.

Authors:  A Nanashima; Y Tagawa; T Nakagoe; J E Nishizawa-Takano; K Hatano; T Uchikawa; Y Matsumoto; Y Taniguchi; N Fujise; H Ayabe
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

Review 3.  Adjuvant chemotherapy for colorectal cancer.

Authors:  Z Rayter; R J Leicester; J L Mansi
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.